4//SEC Filing
LAZAR JACK R 4
Accession 0001277624-25-000007
CIK 0001736297other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 4:10 PM ET
Size
19.6 KB
Accession
0001277624-25-000007
Insider Transaction Report
Form 4
LAZAR JACK R
Director
Transactions
- Sale
Common Stock
2025-11-20$147.57/sh−168$24,793→ 95,977 total - Sale
Common Stock
2025-11-20$154.08/sh−159$24,499→ 95,433 total - Sale
Common Stock
2025-11-20$142.31/sh−168$23,909→ 97,183 total - Sale
Common Stock
2025-11-20$143.60/sh−461$66,200→ 96,722 total - Sale
Common Stock
2025-11-20$145.97/sh−577$84,227→ 96,145 total - Sale
Common Stock
2025-11-20$149.17/sh−219$32,668→ 95,758 total - Sale
Common Stock
2025-11-20$152.67/sh−166$25,343→ 95,592 total - Sale
Common Stock
2025-11-20$157.85/sh−286$45,144→ 95,147 total - Sale
Common Stock
2025-11-20$159.09/sh−296$47,091→ 94,851 total
Footnotes (8)
- [F1]The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2025.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.0850 to $142.5400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.2800 to $143.7650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $145.7200 to $146.2600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.1800 to $147.9700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $154.0000 to $154.9800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.4800 to $158.2200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.0750 to $159.1050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Astera Labs, Inc.
CIK 0001736297
Entity typeother
Related Parties
1- filerCIK 0001277624
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 4:10 PM ET
- Size
- 19.6 KB